IP Library Assignment 022310/0517
Patent Assignment
Reel/Frame 022310/0517

Assignment of Assignor's Interest

Recorded: 2009-02-25 Pages: 7
Assignor
PDL BIOPHARMA, INC.
Executed: 2009-02-10
Assignee
FACET BIOTECH CORPORATION
1500 SEAPORT BOULEVARD, REDWOOD CITY, CALIFORNIA, 94063
Covered Properties (18)
Pharmaceutical Combinations
Chimeric and Humanized Antibodies to ALPHA5BETA1 Integrin That Modulate Angiogenesis
Patent: 7,276,589 →
Application: 10/724,274 →
Publication: US 2005/0054834
Antibodies Against GPR64 and Uses Thereof
Patent: 7,276,372 →
Application: 10/741,657 →
Publication: US 2004/0197325
Methods of production and use of anti-integrin antibodies for the control of tissue granulation
Application: 10/818,068 →
Publication: US 2005/0002930
Chimeric and Humanized Antibodies to ALPHA5BETA1 Integrin That Modulate Angiogenesis
Patent: 7,285,268 →
Application: 10/830,956 →
Publication: US 2005/0163769
Use of Anti-ALPHA5BETA1 Antibodies to Inhibit Cancer Cell Proliferation
Patent: 7,662,384 →
Application: 11/090,331 →
Publication: US 2005/0260210
Stable liquid and lyophilized formulation of proteins
Application: 11/166,906 →
Publication: US 2006/0008415
Chimeric and Humanized Antibodies to ALPHA5BETA1 Integrin That Modulate Angiogenesis
Patent: 7,879,987 →
Application: 11/840,854 →
Publication: US 2009/0259031
Chimeric and Humanized Antibodies to ALPHA5BETA1 Integrin That Modulate Angiogenesis
Patent: 7,776,585 →
Application: 11/840,863 →
Publication: US 2008/0026458
Chimeric and Humanized Antibodies to ALPHA5BETA1 Integrin That Modulate Angiogenesis
Patent: 8,017,116 →
Application: 11/840,871 →
Publication: US 2008/0026033
Chimeric and Humanized Antibodies to ALPHA5BETA1 Integrin That Modulate Angiogenesis
Patent: 7,897,148 →
Application: 11/852,147 →
Publication: US 2008/0260732
Antibodies Against GPR64 and Uses Thereof
Patent: 7,547,544 →
Application: 11/852,155 →
Publication: US 2008/0107642
Pharmaceutical Combinations
Application: 12/181,201 →
Publication: US 2009/0041767
Antibodies Against GPR64 and Uses Thereof
Patent: 7,807,163 →
Application: 12/203,868 →
Publication: US 2009/0117036
Use of Anti-Integrin Antibodies for Reducing Scar Tissue Formation
Application: 12/234,477 →
Publication: US 2009/0041785
Methods of production, evaluation and use in treatment of humanized antibodies that modulate angiogenesis
Application: 60/429,743 →
Stable liquid and lyophilized formulation of proteins
Application: 60/583,127 →
Pharmaceutical Combinations
Application: 60/952,328 →
Related Assignments (16)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 4, 2004
From: JEFFREY, URSULA; RAMAKRISHNAN, VANITHA; POWERS, DAVID; JOHNSON, DALE E.
To: PROTEIN DESIGN LABS, INC.
Reel/Frame 014958/0032 →
Assignment of Assignor's Interest Aug 31, 2004
From: LAW, DEBBIE; WANG, QI; DUBRIDGE, ROBERT; BHASKAR, VINAY
To: PROTEIN DESIGN LABS, INC.
Reel/Frame 015061/0050 →
Assignment of Assignor's Interest Oct 18, 2004
From: JOHNSON, DALE E.; JEFFRY, URSULA
To: PROTEIN DESIGN LABS, INC.
Reel/Frame 015266/0930 →
Assignment of Assignor's Interest Nov 19, 2004
From: RAMAKRISHNAN, VANITHA; POWERS, DAVID; JOHNSON, DALE E.; JEFFRY, URSULA
To: PROTEIN DESIGN LABS, INC.
Reel/Frame 015376/0971 →
Assignment of Assignor's Interest Feb 4, 2005
From: KAISHEVA, ELIZABETH; GUPTA, SUPRIYA; ZHOU, WEICHANG; WEINKAM, ROBERT
To: PROTEIN DESIGN LABS, INC.
Reel/Frame 015650/0729 →
Assignment of Assignor's Interest Mar 30, 2005
From: RAMAKRISHNAN, VANITHA; POWERS, DAVID; JOHNSON, DALE; JEFFRY, URSULA
To: PROTEIN DESIGN LABS, INC
Reel/Frame 015840/0213 →
Assignment of Assignor's Interest Jun 23, 2005
From: RAMAKRISHNAN, VANITHA; BHASKAR, VINAY; HO, SUN; MURRAY, RICHARD
To: PROTEIN DESIGN LABS, INC.
Reel/Frame 016178/0888 →
Assignment of Assignor's Interest Jul 21, 2005
From: KAISHEVA, ELISABET A.; GUPTA, SUPRIYA; ZHOU, WEICHANG; WEINKAM, ROBERT
To: PROTEIN DESIGN LABS, INC.
Reel/Frame 016294/0659 →
Change of Name Apr 17, 2006
From: PROTEIN DESIGN LABS, INC.
To: PDL BIOPHARMA, INC.
Reel/Frame 017482/0827 →
Change of Name May 19, 2006
From: PROTEIN DESIGN LABS, INC.
To: PDL BIOPHARMA, INC.
Reel/Frame 017645/0623 →
Change of Name May 22, 2006
From: PROTEIN DESIGN LABS, INC.
To: PDL BIOPHARMA, INC.
Reel/Frame 017655/0436 →
Assignment of Assignor's Interest Apr 9, 2008
From: RAMAKRISHNAN, VANITHA; BHASKAR, VINAY
To: PDL BIOPHARMA, INC.
Reel/Frame 020779/0172 →
Assignment of Assignor's Interest Oct 20, 2008
From: RAMAKRISHNAN, VANITHA; BHASKAR, VINAY
To: PDL BIOPHARMA, INC.
Reel/Frame 021708/0854 →
Change of Name Dec 7, 2010
From: FACET BIOTECH CORPORATION
To: ABBOTT BIOTHERAPEUTICS CORP.
Reel/Frame 025445/0807 →
Change of Name Feb 18, 2013
From: ABBOTT BIOTHERAPEUTICS CORP
To: ABBVIE BIOTHERAPEUTICS INC.
Reel/Frame 029825/0070 →
Change of Name Dec 20, 2013
From: ABBOTT BIOTHERAPEUTICS CORP
To: ABBVIE BIOTHERAPEUTICS INC.
Reel/Frame 031834/0936 →